These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 19781679

  • 21. Strong immune responses induced by a DNA vaccine containing HPV16 truncated E7 C-terminal linked to HSP70 gene.
    Meshkat Z, Soleimanjahi H, Mirshahabi H, Meshkat M, Kheirandish M, Hassan ZM.
    Iran J Immunol; 2011 Jun; 8(2):65-75. PubMed ID: 21705833
    [Abstract] [Full Text] [Related]

  • 22. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
    Bolhassani A, Zahedifard F, Taghikhani M, Rafati S.
    Vaccine; 2008 Jun 19; 26(26):3362-70. PubMed ID: 18471945
    [Abstract] [Full Text] [Related]

  • 23. A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.
    Tang J, Yin R, Tian Y, Huang Z, Shi J, Fu X, Wang L, Wu Y, Hao F, Ni B.
    Vaccine; 2012 Feb 01; 30(6):1071-82. PubMed ID: 22178528
    [Abstract] [Full Text] [Related]

  • 24. Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model.
    Yu WY, Chuang TF, Guichard C, El-Garch H, Tierny D, Laio AT, Lin CS, Chiou KH, Tsai CL, Liu CH, Li WC, Fischer L, Chu RM.
    Vaccine; 2011 Apr 18; 29(18):3489-500. PubMed ID: 21392590
    [Abstract] [Full Text] [Related]

  • 25. Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity.
    Cheng WF, Lee CN, Su YN, Chai CY, Chang MC, Polo JM, Hung CF, Wu TC, Hsieh CY, Chen CA.
    Cancer Gene Ther; 2006 Sep 18; 13(9):873-85. PubMed ID: 16645621
    [Abstract] [Full Text] [Related]

  • 26. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
    Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X.
    Int J Mol Med; 2012 Dec 18; 30(6):1335-42. PubMed ID: 23027427
    [Abstract] [Full Text] [Related]

  • 27. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
    Huang CY, Chen CA, Lee CN, Chang MC, Su YN, Lin YC, Hsieh CY, Cheng WF.
    Gynecol Oncol; 2007 Dec 18; 107(3):404-12. PubMed ID: 17905417
    [Abstract] [Full Text] [Related]

  • 28. Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs.
    Chen CH, Ji H, Suh KW, Choti MA, Pardoll DM, Wu TC.
    Gene Ther; 1999 Dec 18; 6(12):1972-81. PubMed ID: 10637448
    [Abstract] [Full Text] [Related]

  • 29. DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection.
    Brulet JM, Maudoux F, Thomas S, Thielemans K, Burny A, Leo O, Bex F, Hallez S.
    Eur J Immunol; 2007 Feb 18; 37(2):376-84. PubMed ID: 17274002
    [Abstract] [Full Text] [Related]

  • 30. Boosting with recombinant vaccinia increases HPV-16 E7-Specific T cell precursor frequencies and antitumor effects of HPV-16 E7-expressing Sindbis virus replicon particles.
    Lin CT, Hung CF, Juang J, He L, Lin KY, Kim TW, Wu TC.
    Mol Ther; 2003 Oct 18; 8(4):559-66. PubMed ID: 14529828
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe.
    Trimble C, Lin CT, Hung CF, Pai S, Juang J, He L, Gillison M, Pardoll D, Wu L, Wu TC.
    Vaccine; 2003 Sep 08; 21(25-26):4036-42. PubMed ID: 12922140
    [Abstract] [Full Text] [Related]

  • 32. Human hsp70 and HPV16 oE7 fusion protein vaccine induces an effective antitumor efficacy.
    Zong J, Wang C, Liu B, Liu M, Cao Y, Sun X, Yao Y, Sun G.
    Oncol Rep; 2013 Jul 08; 30(1):407-12. PubMed ID: 23660931
    [Abstract] [Full Text] [Related]

  • 33. Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.
    Sun YY, Peng S, Han L, Qiu J, Song L, Tsai Y, Yang B, Roden RB, Trimble CL, Hung CF, Wu TC.
    Clin Cancer Res; 2016 Feb 01; 22(3):657-69. PubMed ID: 26420854
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic synergy of human papillomavirus E7 subunit vaccines plus cisplatin in an animal tumor model: causal involvement of increased sensitivity of cisplatin-treated tumors to CTL-mediated killing in therapeutic synergy.
    Bae SH, Park YJ, Park JB, Choi YS, Kim MS, Sin JI.
    Clin Cancer Res; 2007 Jan 01; 13(1):341-9. PubMed ID: 17200373
    [Abstract] [Full Text] [Related]

  • 35. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination.
    Cheng WF, Hung CF, Lin KY, Ling M, Juang J, He L, Lin CT, Wu TC.
    Gene Ther; 2003 Aug 01; 10(16):1311-20. PubMed ID: 12883527
    [Abstract] [Full Text] [Related]

  • 36. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P, Pes M, Osen W, Dürst M, Schneider A, Gissmann L, Kaufmann AM.
    Vaccine; 2006 Apr 05; 24(15):2880-93. PubMed ID: 16472545
    [Abstract] [Full Text] [Related]

  • 37. Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines.
    Hauser H, Shen L, Gu QL, Krueger S, Chen SY.
    Gene Ther; 2004 Jun 05; 11(11):924-32. PubMed ID: 15085173
    [Abstract] [Full Text] [Related]

  • 38. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L, Kedl R, Dow S.
    Cancer Gene Ther; 2006 Nov 05; 13(11):1033-44. PubMed ID: 16841080
    [Abstract] [Full Text] [Related]

  • 39. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A, Bolhassani A, Rafati S, Zahedifard F, Hosseinzadeh S, Doustdari F.
    Immunol Lett; 2012 Dec 17; 148(2):117-25. PubMed ID: 23085605
    [Abstract] [Full Text] [Related]

  • 40. Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection.
    Kim TY, Myoung HJ, Kim JH, Moon IS, Kim TG, Ahn WS, Sin JI.
    Cancer Res; 2002 Dec 15; 62(24):7234-40. PubMed ID: 12499264
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.